Federal award
KBR WYLE SERVICES, LLC
0014
Contract
Obligated and Ceiling
- Obligated (net)
- $3,325,407.70
- Ceiling (potential value, not spending)
- $0.00
- Current value
- $0.00
- Gross positive obligations
- $3,331,087.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of War · sub-agency 9763 · office S0107A
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0014
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 22 · Jan 11, 2008 to Aug 16, 2016
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History22
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 16, 2016 | FY2016 | 1A | C | −$5,679.30 | |
| Feb 22, 2010 | FY2010 | 28 | C | $72,140.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 27, 2009 | FY2009 | 27 | C | $141,063.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 24, 2009 | FY2009 | 26 | C | $324,843.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 10, 2009 | FY2009 | 25 | C | $28,986.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 31, 2009 | FY2009 | 24 | C | $324,843.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 31, 2008 | FY2009 | 23 | C | $366,246.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 22, 2008 | FY2009 | 22 | C | $163,036.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 23, 2008 | FY2008 | 21 | C | $386,473.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 19, 2008 | FY2008 | 20 | C | $9,964.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 16, 2008 | FY2008 | 19 | C | $193,237.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 15, 2008 | FY2008 | 18 | C | $90,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 3, 2008 | FY2008 | 17 | C | $80,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 19, 2008 | FY2008 | 16 | C | $433,165.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 16, 2008 | FY2008 | 15 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 15, 2008 | FY2008 | 14 | C | $250,753.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 13, 2008 | FY2008 | 13 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 24, 2008 | FY2008 | 12 | C | $243,388.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 31, 2008 | FY2008 | 11 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 26, 2008 | FY2008 | 10 | C | $131,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 14, 2008 | FY2008 | 9 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 11, 2008 | FY2008 | 8 | C | $91,450.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
